2C (2C-x) is the general name for the family of phenethylamines containing two methoxy groups at the 2 and 5 positions of the benzene ring. The abuse of 2C family drugs has grown rapidly, although the abuse potential and neurotoxic properties of 2C drugs have not yet been fully investigated. In this study, we investigated the abuse potential and neurotoxicity of 4-chloro-2,5-dimethoxyphenethylamine (2C-C) and 2,5-dimethoxy-4-propylphenethylamine (2C-P). We found that 2C-C and 2C-P produced conditioned place preference in a dose-dependent manner in mice, and increased self-administration in rats, suggesting that 2C-C and 2C-P have abuse potential. To investigate the neurotoxicity of 2C-C and 2C-P, we examined motor performance and memory impairment after high doses of 2C-C and 2C-P. High doses of 2C-C and 2C-P decreased locomotor activity, rota-rod performance, and lower Y-maze test, novel objective recognition test, and passive avoidance test scores. We also observed that 2C-C and 2C-P affected expression levels of the D1 dopamine receptor, D2 dopamine receptor, dopamine transporter, and phospho-dopamine transporter in the nucleus accumbens and the medial prefrontal cortex, and increased c-Fos immuno-positive cells in the nucleus accumbens. Moreover, high doses of 2C-C and 2C-P induced microglial activation, which is involved in the inflammatory reaction in the striatum. These results suggest that 2C-C and 2C-P have abuse potential by affecting dopaminergic signaling and induce neurotoxicity via initiating neuroinflammation at high doses.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Abou Baker DH, Ibrahim BMM, Hassan NS, Yousuf AF, Gengaihi SE (2020) Exploiting Citrus aurantium seeds and their secondary metabolites in the management of Alzheimer disease. Toxicol Rep 7:723–729. https://doi.org/10.1016/j.toxrep.2020.06.001
Aloizou AM, Siokas V, Sapouni EM et al (2020) Parkinson’s disease and pesticides: are microRNAs the missing link? Sci Total Environ 744:140591. https://doi.org/10.1016/j.scitotenv.2020.140591
Ares-Santos S, Granado N, Oliva I, O’Shea E, Martin ED, Colado MI, Moratalla R (2012) Dopamine D1 receptor deletion strongly reduces neurotoxic effects of methamphetamine. Neurobiol Dis 45(2):810–820. https://doi.org/10.1016/j.nbd.2011.11.005
Asanuma M, Miyazaki I, Funada M (2020) The neurotoxicity of psychoactive phenethylamines “2C series” in cultured monoaminergic neuronal cell lines. Forensic Toxicol 38(2):394–408. https://doi.org/10.1007/s11419-020-00527-w
Bachiller S, Jimenez-Ferrer I, Paulus A, Yang Y, Swanberg M, Deierborg T, Boza-Serrano A (2018) Microglia in neurological diseases: a road map to brain-disease dependent-inflammatory response. Front Cell Neurosci 12:488. https://doi.org/10.3389/fncel.2018.00488
Bartlett SE, Enquist J, Hopf FW et al (2005) Dopamine responsiveness is regulated by targeted sorting of D2 receptors. ProcNatlAcadSci USA 102(32):11521–11526. https://doi.org/10.1073/pnas.0502418102
Beirami E, Oryan S, SeyedhosseiniTamijani SM, Ahmadiani A, Dargahi L (2018) Intranasal insulin treatment restores cognitive deficits and insulin signaling impairment induced by repeated methamphetamine exposure. J Cell Biochem 119(2):2345–2355. https://doi.org/10.1002/jcb.26398
Block ML, Zecca L, Hong JS (2007) Microglia-mediated neurotoxicity: uncovering the molecular mechanisms. Nat Rev Neurosci 8(1):57–69. https://doi.org/10.1038/nrn2038
Botanas CJ, Yoon SS, de la Pena JB et al (2017) The abuse potential of alpha-Piperidinopropiophenone (PIPP) and alpha-Piperidinopentiothiophenone (PIVT), two new synthetic cathinones with piperidine ring substituent. BiomolTher (Seoul) 25(2):122–129. https://doi.org/10.4062/biomolther.2016.241
Braren SH, Drapala D, Tulloch IK, Serrano PA (2014) Methamphetamine-induced short-term increase and long-term decrease in spatial working memory affects protein Kinase M zeta (PKMzeta), dopamine, and glutamate receptors. Front BehavNeurosci 8:438. https://doi.org/10.3389/fnbeh.2014.00438
Cervinski MA, Foster JD, Vaughan RA (2005) Psychoactive substrates stimulate dopamine transporter phosphorylation and down-regulation by cocaine-sensitive and protein kinase C-dependent mechanisms. J BiolChem 280(49):40442–40449. https://doi.org/10.1074/jbc.M501969200
Chauhan H, Killinger BA, Miller CV, Moszczynska A (2014) Single and binge methamphetamine administrations have different effects on the levels of dopamine D2 autoreceptor and dopamine transporter in rat striatum. Int J MolSci 15(4):5884–5906. https://doi.org/10.3390/ijms15045884
Cole RD, Wolsh C, Zimmerman M, Harrington E, Gould TJ, Parikh V (2019) Adolescent and adult nicotine exposure differentially impacts oral nicotine and oral saccharin self-administration in mice. Behav Brain Res 359:836–844. https://doi.org/10.1016/j.bbr.2018.07.019
Cole RL, Konradi C, Douglass J, Hyman SE (1995) Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron 14(4):813–823. https://doi.org/10.1016/0896-6273(95)90225-2
Çomaklı S, Sevim Ç, Kontadakis G et al (2019) Acute glufosinate-based herbicide treatment in rats leads to increased ocular interleukin-1β and c-Fos protein levels, as well as intraocular pressure. Toxicol Rep 6:155–160. https://doi.org/10.1016/j.toxrep.2019.01.004
Cornish JL, Hunt GE, Robins L, McGregor IS (2012) Regional c-Fos and FosB/DeltaFosB expression associated with chronic methamphetamine self-administration and methamphetamine-seeking behavior in rats. Neuroscience 206:100–114. https://doi.org/10.1016/j.neuroscience.2012.01.004
Curtin K, Fleckenstein AE, Robison RJ, Crookston MJ, Smith KR, Hanson GR (2015) Methamphetamine/amphetamine abuse and risk of Parkinson’s disease in Utah: a population-based assessment. Drug Alcohol Depend 146:30–38. https://doi.org/10.1016/j.drugalcdep.2014.10.027
Custodio RJP, Sayson LV, Botanas CJ et al (2019) 25B-NBOMe, a novel N-2-methoxybenzyl-phenethylamine (NBOMe) derivative, may induce rewarding and reinforcing effects via a dopaminergic mechanism: Evidence of abuse potential. Addict Biol. https://doi.org/10.1111/adb.12850
Dardiotis E, Aloizou AM, Sakalakis E et al (2020) Organochlorine pesticide levels in Greek patients with Parkinson’s disease. Toxicol Rep 7:596–601. https://doi.org/10.1016/j.toxrep.2020.03.011
Daza-Losada M, Ribeiro Do Couto B, Manzanedo C, Aguilar MA, Rodriguiz-Arias M, Minarro J (2007) Rewarding effects and reinstatement of MDMA-induced CPP in adolescent mice. Neuropsychopharmacology 32(8):1750–1759. https://doi.org/10.1038/sj.npp.1301309
Davidson C, Gow AJ, Lee TH, Ellinwood EH (2001) Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and relevance to human abuse and treatment. Brain Res Brain Res Rev 36(1):1–22. https://doi.org/10.1016/s0165-0173(01)00054-6
Dean BV, Stellpflug SJ, Burnett AM, Engebretsen KM (2013) 2C or not 2C: phenethylamine designer drug review. J Med Toxicol 9(2):172–178. https://doi.org/10.1007/s13181-013-0295-x
Elmore JS, Decker AM, Sulima A, Rice KC, Partilla JS, Blough BE, Baumann MH (2018) Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats. Neuropharmacology 142:240–250. https://doi.org/10.1016/j.neuropharm.2018.02.033
Eshleman AJ, Forster MJ, Wolfrum KM, Johnson RA, Janowsky A, Gatch MB (2014) Behavioral and neurochemical pharmacology of six psychoactive substituted phenethylamines: mouse locomotion, rat drug discrimination and in vitro receptor and transporter binding and function. Psychopharmacology 231(5):875–888. https://doi.org/10.1007/s00213-013-3303-6
FDA (2017) Assessment of abuse potential of drugs guidance for industry. Food and Drug administration, pp 1–37. Retrieved from https://www.fda.gov/media/116739/download
Foster JD, Vaughan RA (2017) Phosphorylation mechanisms in dopamine transporter regulation. J ChemNeuroanat 83–84:10–18. https://doi.org/10.1016/j.jchemneu.2016.10.004
Galaj E, Bi GH, Moore A et al (2020) Beta-caryophyllene inhibits cocaine addiction-related behavior by activation of PPARα and PPARγ: repurposing a FDA-approved food additive for cocaine use disorder. Neuropsychopharmacology. https://doi.org/10.1038/s41386-020-00885-4
Gannon BM, Baumann MH, Walther D et al (2018) The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter. Neuropsychopharmacology. https://doi.org/10.1038/s41386-018-0209-3
Gehrke BJ, Harrod SB, Cass WA, Bardo MT (2003) The effect of neurotoxic doses of methamphetamine on methamphetamine-conditioned place preference in rats. Psychopharmacology 166(3):249–257. https://doi.org/10.1007/s00213-002-1318-5
Gilbert DB, Cooper SJ (1985) β-Phenylethylamine and amphetamine compared in tests of anorexia and place-preference conditioning. In: Boulton AA, Maitre L, Bieck PR, Riederer P (eds) Neuropsychopharmacology of the trace amines: experimental and clinical aspects. Humana Press, Totowa, NJ, pp 187–193
GovTrack.us (2012) S. 3187 112th Congress: food and drug administration safety and innovation act., 112th edn. Retrieved from https://www.govinfo.gov/content/pkg/BILLS-112s3187enr/pdf/BILLS-112s3187enr.pdf
Hansen DV, Hanson JE, Sheng M (2018) Microglia in Alzheimer’s disease. J Cell Biol 217(2):459–472. https://doi.org/10.1083/jcb.201709069
Ikemoto S, Wise RA (2002) Rewarding effects of the cholinergic agents carbachol and neostigmine in the posterior ventral tegmental area. J Neurosci 22(22):9895. https://doi.org/10.1523/JNEUROSCI.22-22-09895.2002
Liddelow SA, Guttenplan KA, Clarke LE et al (2017) Neurotoxic reactive astrocytes are induced by activated microglia. Nature 541:481–487. https://doi.org/10.1038/nature21029
Luikinga SJ, Perry CJ, Madsen HB, Lawrence AJ, Kim JH (2019) Effects of methamphetamine exposure on fear learning and memory in adult and adolescent rats. Neurochem Res 44(9):2081–2091. https://doi.org/10.1007/s11064-019-02845-x
Nagai F, Nonaka R, Satoh HisashiKamimura K (2007) The effects of non-medically used psychoactive drugs on monoamine neurotransmission in rat brain. Eur J Pharmacol 559(2–3):132–137. https://doi.org/10.1016/j.ejphar.2006.11.075
Nestler EJ (2012) Transcriptional mechanisms of drug addiction. ClinPsychopharmacolNeurosci 10(3):136–143. https://doi.org/10.9758/cpn.2012.10.3.136
Noda Y, Mouri A, Ando Y et al (2010) Galantamine ameliorates the impairment of recognition memory in mice repeatedly treated with methamphetamine: involvement of allosteric potentiation of nicotinic acetylcholine receptors and dopaminergic-ERK1/2 systems. Int J Neuropsychopharm 13(10):1343–1354. https://doi.org/10.1017/S1461145710000222
Rickli A, Luethi D, Reinisch J, Buchy D, Hoener MC, Liechti ME (2015) Receptor interaction profiles of novel N-2-methoxybenzyl (NBOMe) derivatives of 2,5-dimethoxy-substituted phenethylamines (2C drugs). Neuropharmacology 99:546–553. https://doi.org/10.1016/j.neuropharm.2015.08.034
Russo SJ, Nestler EJ (2013) The brain reward circuitry in mood disorders. Nat Rev Neurosci 14(9):609–625. https://doi.org/10.1038/nrn3381
Seo JY, Hur KH, Ko YH et al (2019) A novel designer drug, 25N-NBOMe, exhibits abuse potential via the dopaminergic system in rodents. Brain Res Bull 152:19–26. https://doi.org/10.1016/j.brainresbull.2019.07.002
Shulgin AT, Shulgin A (1990) PiHKAL, The chmical love story. Transform Press, Berkely
Siokas V, Aslanidou P, Aloizou AM et al (2020) Does the CD33 rs3865444 polymorphism confer susceptibility to alzheimer’s disease? J MolNeurosci 70(6):851–860. https://doi.org/10.1007/s12031-020-01507-w
Sofroniew MV, Vinters HV (2010) Astrocytes: biology and pathology. ActaNeuropathol 119(1):7–35. https://doi.org/10.1007/s00401-009-0619-8
Spanagel R (2017) Animal models of addiction. Dialog ClinNeurosci 19(3):247–258. https://doi.org/10.31887/DCNS.2017.19.3/rspanagel
Stephenson CP, Hunt GE, Topple AN, McGregor IS (1999) The distribution of 3,4-methylenedioxymethamphetamine “Ecstasy”-induced c-fos expression in rat brain. Neuroscience 92(3):1011–1023. https://doi.org/10.1016/S0306-4522(99)00049-4
Stoller A, Dolder PC, Bodmer M et al (2017) Mistaking 2C-P for 2C-B: what a difference a letter makes. J Anal Toxicol 41(1):77–79. https://doi.org/10.1093/jat/bkw108
Teixeira-Gomes A, Costa VM, Feio-Azevedo R, BastosMde L, Carvalho F, Capela JP (2015) The neurotoxicity of amphetamines during the adolescent period. Int J Dev Neurosci 41:44–62. https://doi.org/10.1016/j.ijdevneu.2014.12.001
Thomas DM, Walker PD, Benjamins JA, Geddes TJ, Kuhn DM (2004) Methamphetamine neurotoxicity in dopamine nerve endings of the striatum is associated with microglial activation. J PharmacolExpTher 311(1):1–7. https://doi.org/10.1124/jpet.104.070961
Volkow ND, Fowler JS, Wang GJ (2002) Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies. BehavPharmacol 13(5–6):355–366. https://doi.org/10.1097/00008877-200209000-00008
Volkow ND, Wise RA, Baler R (2017) The dopamine motive system: implications for drug and food addiction. Nat Rev Neurosci 18(12):741–752. https://doi.org/10.1038/nrn.2017.130
Xu W, Zhu JP, Angulo JA (2005) Induction of striatal pre- and postsynaptic damage by methamphetamine requires the dopamine receptors. Synapse (New York, NY) 58(2):110–121. https://doi.org/10.1002/syn.20185
This research was supported by the Ministry of Food and Drug Safety (14182MFDS979 and 19182MFDS403) and the National Research Foundation of Korea (2020R1F1A1072302).
Conflict of interest
The authors declare no conflicts of interest.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Kim, YJ., Ma, SX., Hur, KH. et al. New designer phenethylamines 2C-C and 2C-P have abuse potential and induce neurotoxicity in rodents. Arch Toxicol 95, 1413–1429 (2021). https://doi.org/10.1007/s00204-021-02980-x
- Abuse potential